US Patent Issued to Horizon Therapeutics Ireland DAC on Sept. 23 for "Binding molecules specific for fcGammaRIIA and uses thereof" (British, American Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,314, issued on Sept. 23, was assigned to Horizon Therapeutics Ireland DAC (Dublin).

"Binding molecules specific for fcGammaRIIA and uses thereof" was invented by Katherine Ann Vousden (Cambridgeshire, Great Britain), Bo Chen (Frederick, Md.) and Gary Patrick Sims (Potomac, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides FcGammaRIIA-binding molecules, for example, humanized monoclonal antibodies capable of inhibiting FcGammaRIIA activity, and methods of using the FcGammaRIIA binding molecules, for example, in treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders."

The patent was filed o...